122 related articles for article (PubMed ID: 36585906)
21. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
22. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition.
He A; He S; Huang C; Chen Z; Wu Y; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Jan; 12(2):1465-1487. PubMed ID: 31978894
[TBL] [Abstract][Full Text] [Related]
23. Bromodomain-containing protein 9 is a prognostic biomarker associated with immune infiltrates and promotes tumor malignancy through activating notch signaling pathway in negative HIF-2α clear cell renal cell carcinoma.
Lou W; Gao K; Xu C; Li Q
IUBMB Life; 2021 Nov; 73(11):1334-1347. PubMed ID: 34415102
[TBL] [Abstract][Full Text] [Related]
24. RBM4 modulates the proliferation and expression of inflammatory factors via the alternative splicing of regulatory factors in HeLa cells.
Wang WY; Quan W; Yang F; Wei YX; Chen JJ; Yu H; Xie J; Zhang Y; Li ZF
Mol Genet Genomics; 2020 Jan; 295(1):95-106. PubMed ID: 31489484
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
Huang S; Hou Y; Hu M; Hu J; Liu X
BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma.
Hu W; Su Y; Fei X; Wang X; Zhang G; Su C; Du T; Yang T; Wang G; Tang Z; Zhang J
Oncol Rep; 2020 Jun; 43(6):1964-1974. PubMed ID: 32236633
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of TP53INP2 Promotes Apoptosis in Clear Cell Renal Cell Cancer via Caspase-8/TRAF6 Signaling Pathway.
Li X; Hu D; Li Y; Luo Y; Liang B; Yu K; Xiong W; Zuo D
J Immunol Res; 2022; 2022():1260423. PubMed ID: 35615533
[TBL] [Abstract][Full Text] [Related]
28. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
[TBL] [Abstract][Full Text] [Related]
29. AMG232 inhibits angiogenesis in glioma through the p53-RBM4-VEGFR2 pathway.
Xiao Y; Li M; Ma T; Ning H; Liu L
J Cell Sci; 2023 Jan; 136(2):. PubMed ID: 36601864
[TBL] [Abstract][Full Text] [Related]
30. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
31. Circ_RPL23A acts as a miR-1233 sponge to suppress the progression of clear cell renal cell carcinoma by promoting ACAT2.
Cheng L; Cao H; Xu J; Xu M; He W; Zhang W; Dong L; Chen D
J Bioenerg Biomembr; 2021 Aug; 53(4):415-428. PubMed ID: 34036483
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
Huang JL; Liao Y; Qiu MX; Li J; An Y
Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
[TBL] [Abstract][Full Text] [Related]
33. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
[TBL] [Abstract][Full Text] [Related]
34. Silent information regulator 2 promotes clear cell renal cell carcinoma progression through deacetylation and small ubiquitin-related modifier 1 modification of glucose 6-phosphate dehydrogenase.
Ni Y; Yang Z; Agbana YL; Bai H; Wang L; Yang L; Yi Z; Cheng J; Zhang Q; Kuang Y; Zhu Y
Cancer Sci; 2021 Oct; 112(10):4075-4086. PubMed ID: 34310804
[TBL] [Abstract][Full Text] [Related]
35. G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS‑MAPK axis pathway.
Zhang Q; Han Q; Yang Z; Ni Y; Agbana YL; Bai H; Yi Z; Yi X; Kuang Y; Zhu Y
Int J Oncol; 2020 Jul; 57(1):197-212. PubMed ID: 32319593
[TBL] [Abstract][Full Text] [Related]
36. RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma.
Chen W; Niu S; Ma X; Zhang P; Gao Y; Fan Y; Pang H; Gong H; Shen D; Gu L; Zhang Y; Zhang X
PLoS One; 2016; 11(7):e0157599. PubMed ID: 27384222
[TBL] [Abstract][Full Text] [Related]
37. LTB4R Promotes the Occurrence and Progression of Clear Cell Renal Cell Carcinoma (ccRCC) by Regulating the AKT/mTOR Signaling Pathway.
Zhang X; Wu H; Yan X; Ma J; Chen Z
Cells; 2022 Nov; 11(22):. PubMed ID: 36429034
[TBL] [Abstract][Full Text] [Related]
38. VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma.
Razafinjatovo CF; Stiehl D; Deininger E; Rechsteiner M; Moch H; Schraml P
Oncotarget; 2017 Feb; 8(6):10199-10212. PubMed ID: 28052007
[TBL] [Abstract][Full Text] [Related]
39. Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway.
Li L; Li M; Zheng J; Li Z; Chen X
Aging (Albany NY); 2023 Jun; 15(11):4757-4773. PubMed ID: 37263638
[TBL] [Abstract][Full Text] [Related]
40. SIRT5 functions as a tumor suppressor in renal cell carcinoma by reversing the Warburg effect.
Yihan L; Xiaojing W; Ao L; Chuanjie Z; Haofei W; Yan S; Hongchao H
J Transl Med; 2021 Dec; 19(1):521. PubMed ID: 34930316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
